Vector Laboratories Acquires Quanta Biodesign To Continue Growth Strategy Of Strengthening Development And Manufacturing Services For Life Science And Biopharma Customers

Jul 17, 2023•about 2 years ago

Acquiring Company

Vector Labs

Acquired Company

Quanta BioDesign

Description

Vector Laboratories, the pioneer of innovative proteomic and glycomic research solutions, today announced the acquisition of Quanta BioDesign, the inventor of discrete polyethylene glycol (dPEG®) technology for advanced bioconjugate and payload delivery design for life science and biopharma applications. This most recent acquisition further expands Vector Laboratories’ portfolio of bioconjugation linkers and dyes and builds on its manufacturing and bioconjugation capabilities to better serve partners across biopharma and the life sciences.

Company Information

Company

Vector Labs

About

Vector Laboratories is a manufacturer of reagents and critical components for the development and production of life sciences tools, diagnostics, and clinical stage biotherapeutics. Absolute Biotech is a global manufacturer and supplier, serving customers with antibody reagents, kits, and services to support annotation, validation, sequencing, engineering, and recombinant antibody manufacturing.

Related People

M&A Insights

Based on deal data

Integration timeline

70% of M&A integrations take 12-24 months to complete

Tech stack consolidation

83% of merged companies consolidate technology vendors within first year

Post-acquisition investment

Companies increase IT spending by 23% on average after acquisitions

Success factor

M&A deals with strong technology integration plans are 2.5x more likely to succeed